The market cap for Gilead Sciences is $68.81 billion and its P/E ratio is 13.86. hewlett packard hpq On October 5 th before the official announcement, Morgan Stanley analyst Kathryn Huberty reiterated an Overweight rating on HP with a $40 price target. She noted, "While PC and Printers are run on a combined basis already, a change HP CEO Meg Whitman made in March 2012, we would expect incremental costs and/or reduced scale if the business was run without the current shared cost structure. Other potential influences on valuation could include increased leverage on the HP PC + Printer balance sheet that provides HP Enterprise with liquidity for M&A and/or potential tax rate fluctuations up/down based on the company's ability to repatriate international cash.